Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)
Conclusions
The results indicate no increased risk of mortality or incidence of cancer, stroke, or MI in adult GH-deficient patients who had previously received pediatric GH treatment.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Children | Endocrinology | Heart Attack | Hormones | Pediatrics | Stroke | Study